title: [Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?].
authors.affiliation: Onkologische Arbeitsgruppe der I. Universitäts-Frauenklinik Wien.
authors.forename: P
authors.initials: P
authors.lastname: Sevelda
authors.forename: A
authors.initials: A
authors.lastname: Rosen
authors.forename: M
authors.initials: M
authors.lastname: Barrada
authors.forename: S
authors.initials: S
authors.lastname: Gober
authors.forename: N
authors.initials: N
authors.lastname: Vavra
authors.forename: H
authors.initials: H
authors.lastname: Salzer
mesh_terms: D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D005188:False Negative Reactions; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000175:diagnosis*; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000601:surgery; D011863:Radioimmunoassay; D012189:Retrospective Studies
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor
vernacular_title: Ist die Verlaufskontrolle falsch negativer CA-125 Serumwerte in der Tumornachsorge des Ovarialkarzinoms sinnvoll?